Answer
Bulevirtide acetate blocks hepatitis B and D viruses from entering liver cells by binding to and inactivating NTCP, a liver bile salt transporter that serves as an essential entry receptor for both viruses.
Sources for this answer
- HEPCLUDEX 2 mg powder for solution for injectionGilead Sciences Ltd · emc · SmPC §5.1 Pharmacodynamic properties · Version 8Document updated
Sources checked